Literature DB >> 26403194

Regulation of innate immune cell function by mTOR.

Thomas Weichhart1, Markus Hengstschläger1, Monika Linke1.   

Abstract

The innate immune system is central for the maintenance of tissue homeostasis and quickly responds to local or systemic perturbations by pathogenic or sterile insults. This rapid response must be metabolically supported to allow cell migration and proliferation and to enable efficient production of cytokines and lipid mediators. This Review focuses on the role of mammalian target of rapamycin (mTOR) in controlling and shaping the effector responses of innate immune cells. mTOR reconfigures cellular metabolism and regulates translation, cytokine responses, antigen presentation, macrophage polarization and cell migration. The mTOR network emerges as an integrative rheostat that couples cellular activation to the environmental and intracellular nutritional status to dictate and optimize the inflammatory response. A detailed understanding of how mTOR metabolically coordinates effector responses by myeloid cells will provide important insights into immunity in health and disease.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26403194      PMCID: PMC6095456          DOI: 10.1038/nri3901

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  165 in total

1.  Neutrophils alter the inflammatory milieu by signal-dependent translation of constitutive messenger RNAs.

Authors:  Stephan W Lindemann; Christian C Yost; Melvin M Denis; Thomas M McIntyre; Andrew S Weyrich; Guy A Zimmerman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

Review 2.  Current treatment strategies for inhibiting mTOR in cancer.

Authors:  Francesca Chiarini; Camilla Evangelisti; James A McCubrey; Alberto M Martelli
Journal:  Trends Pharmacol Sci       Date:  2014-12-11       Impact factor: 14.819

Review 3.  Immunoregulatory functions of mTOR inhibition.

Authors:  Angus W Thomson; Hēth R Turnquist; Giorgio Raimondi
Journal:  Nat Rev Immunol       Date:  2009-05       Impact factor: 53.106

4.  Participation of mammalian target of rapamycin complex 1 in Toll-like receptor 2- and 4-induced neutrophil activation and acute lung injury.

Authors:  Emmanuel Lorne; Xia Zhao; Jaroslaw W Zmijewski; Gang Liu; Young-Jun Park; Yuko Tsuruta; Edward Abraham
Journal:  Am J Respir Cell Mol Biol       Date:  2009-01-08       Impact factor: 6.914

5.  The TSC-mTOR signaling pathway regulates the innate inflammatory response.

Authors:  Thomas Weichhart; Giuseppina Costantino; Marko Poglitsch; Margit Rosner; Maximilian Zeyda; Karl M Stuhlmeier; Thomas Kolbe; Thomas M Stulnig; Walter H Hörl; Markus Hengstschläger; Mathias Müller; Marcus D Säemann
Journal:  Immunity       Date:  2008-10-09       Impact factor: 31.745

6.  Rapamycin, but not cyclosporine or FK506, alters natural killer cell function.

Authors:  Lu-En Wai; Masato Fujiki; Saori Takeda; Olivia M Martinez; Sheri M Krams
Journal:  Transplantation       Date:  2008-01-15       Impact factor: 4.939

7.  Macrophage PTEN regulates expression and secretion of arginase I modulating innate and adaptive immune responses.

Authors:  Emine Sahin; Stefan Haubenwallner; Mario Kuttke; Isabella Kollmann; Angela Halfmann; Alexander M Dohnal; Alexander B Dohnal; Li Chen; Paul Cheng; Bastian Hoesel; Elisa Einwallner; Julia Brunner; Julia B Kral; Waltraud C Schrottmaier; Kathrin Thell; Victoria Saferding; Stephan Blüml; Gernot Schabbauer
Journal:  J Immunol       Date:  2014-07-11       Impact factor: 5.422

Review 8.  Non-canonical functions of the tuberous sclerosis complex-Rheb signalling axis.

Authors:  Nicole A Neuman; Elizabeth Petri Henske
Journal:  EMBO Mol Med       Date:  2011-03-16       Impact factor: 12.137

9.  LAMTOR2 regulates dendritic cell homeostasis through FLT3-dependent mTOR signalling.

Authors:  Julia M Scheffler; Florian Sparber; Christoph H Tripp; Caroline Herrmann; Alexandra Humenberger; Johanna Blitz; Nikolaus Romani; Patrizia Stoitzner; Lukas A Huber
Journal:  Nat Commun       Date:  2014-10-22       Impact factor: 14.919

Review 10.  Metabolic reprograming in macrophage polarization.

Authors:  Silvia Galván-Peña; Luke A J O'Neill
Journal:  Front Immunol       Date:  2014-09-02       Impact factor: 7.561

View more
  261 in total

Review 1.  A guide to immunometabolism for immunologists.

Authors:  Luke A J O'Neill; Rigel J Kishton; Jeff Rathmell
Journal:  Nat Rev Immunol       Date:  2016-07-11       Impact factor: 53.106

2.  Deficiency of Socs3 leads to brain-targeted EAE via enhanced neutrophil activation and ROS production.

Authors:  Zhaoqi Yan; Wei Yang; Luke Parkitny; Sara A Gibson; Kevin S Lee; Forrest Collins; Jessy S Deshane; Wayne Cheng; Amy S Weinmann; Hairong Wei; Hongwei Qin; Etty N Benveniste
Journal:  JCI Insight       Date:  2019-04-02

3.  Glycolytic requirement for NK cell cytotoxicity and cytomegalovirus control.

Authors:  Annelise Y Mah; Armin Rashidi; Molly P Keppel; Nermina Saucier; Emily K Moore; Joshua B Alinger; Sandeep K Tripathy; Sandeep K Agarwal; Emily K Jeng; Hing C Wong; Jeffrey S Miller; Todd A Fehniger; Emily M Mace; Anthony R French; Megan A Cooper
Journal:  JCI Insight       Date:  2017-12-07

Review 4.  MenTORing Immunity: mTOR Signaling in the Development and Function of Tissue-Resident Immune Cells.

Authors:  Russell G Jones; Edward J Pearce
Journal:  Immunity       Date:  2017-05-16       Impact factor: 31.745

5.  Mammalian target of rapamycin regulates a hyperresponsive state in pulmonary neutrophils late after burn injury.

Authors:  Julia L M Dunn; Laurel B Kartchner; Karli Gast; Marci Sessions; Rebecca A Hunter; Lance Thurlow; Anthony Richardson; Mark Schoenfisch; Bruce A Cairns; Robert Maile
Journal:  J Leukoc Biol       Date:  2018-02-02       Impact factor: 4.962

Review 6.  Metabolic Alterations in Cancer and Their Potential as Therapeutic Targets.

Authors:  Jamie D Weyandt; Craig B Thompson; Amato J Giaccia; W Kimryn Rathmell
Journal:  Am Soc Clin Oncol Educ Book       Date:  2017

Review 7.  AKT/PKB Signaling: Navigating the Network.

Authors:  Brendan D Manning; Alex Toker
Journal:  Cell       Date:  2017-04-20       Impact factor: 41.582

Review 8.  HIF1α and metabolic reprogramming in inflammation.

Authors:  Sarah E Corcoran; Luke A J O'Neill
Journal:  J Clin Invest       Date:  2016-08-29       Impact factor: 14.808

9.  Mammalian Target of Rapamycin Inhibition With Rapamycin Mitigates Radiation-Induced Pulmonary Fibrosis in a Murine Model.

Authors:  Eun Joo Chung; Anastasia Sowers; Angela Thetford; Grace McKay-Corkum; Su I Chung; James B Mitchell; Deborah E Citrin
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-07-28       Impact factor: 7.038

10.  Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis.

Authors:  Shih-Chin Cheng; Brendon P Scicluna; Rob J W Arts; Mark S Gresnigt; Ekta Lachmandas; Evangelos J Giamarellos-Bourboulis; Matthijs Kox; Ganesh R Manjeri; Jori A L Wagenaars; Olaf L Cremer; Jenneke Leentjens; Anne J van der Meer; Frank L van de Veerdonk; Marc J Bonten; Marcus J Schultz; Peter H G M Willems; Peter Pickkers; Leo A B Joosten; Tom van der Poll; Mihai G Netea
Journal:  Nat Immunol       Date:  2016-03-07       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.